Baxter Anticoagulant Sodium Citrate Solution recalled for potential fiberglass contamination
What this means
Baxter is recalling one lot of Anticoagulant Sodium Citrate Solution used with apheresis devices due to potential fiberglass particles in the solution. The affected product was distributed to one customer in the United States between July 2 and July 11, 2026. No adverse events have been reported to date.
- If you received this product (lot Y493475, expiration 12/31/2027), stop using it immediately.
- Return all affected units to your facility according to your facility's process.
- Contact Baxter Healthcare Center for Service at 888-229-0001 (Monday–Friday, 7 am–6 pm Central) for return instructions.
- Report any adverse reactions to FDA MedWatch at 1-800-332-1088 or www.fda.gov/medwatch/report.htm.
Product photos
The agency's original wording
FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Anticoagulant Sodium Citrate Solution due to the potential presence of particulate matter identified as fiberglass in the solution.
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-one-lot-anticoagulant-sodium-citrate-solution-dueMore Baxter recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.